# A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV

> **NCT06652958** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **ViiV Healthcare** · enrollment: 102 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** VH4527079

## Key facts

- **NCT ID:** NCT06652958
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-02
- **Primary completion:** 2026-09-09
- **Final completion:** 2026-09-09
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06652958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06652958, "A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06652958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*